Nath Bio-Genes to Consider Q2 and H1 FY27 Financial Results on 14th Nov'26
Nath Bio-Genes (India) Ltd 路 Intimation 路 14 Nov 2026, 5:30 am
Nath Bio-Genes to Consider Q2 and H1 FY27 Financial Results on 14th Nov'26 Nath Bio-Genes (India) Ltd has scheduled a Board of Directors meeting on 14th Nov'26 to consider, approve, and take on record the standalone and consolidated unaudited financial results for the quarter and half year ended 30th Sep'26. In accordance with insider trading regulations, the company's trading window closed on 30th Sep'26 and will reopen on 17th Nov'26.
Original exchange filing (PDF)
More announcements from Nath Bio-Genes (India) Ltd
- Audio Transcript of Conference Call held on 16th November 2026 路 17 Nov 2026
- Presentation on Unaudited Financial Results as of 30th September 2026 路 16 Nov 2026
- Nath Bio-Genes (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 14 Nov 2026
- Unaudited Standalone and Consolidated Financial Results as on 30th September 2026 路 14 Nov 2026
- Intimation about Conference call to be held on 16th November 2026 at 04:00 PM 路 16 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 14 Nov 2026
- NATH BIO-GENES (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . 路 14 Nov 2026
- Proceedings of AGM and Scrutinizers report for AGM held on 24th September 2026 路 24 Sept 2026
